Sunosi Interactions
Showing entire list of all interactions, including brand names and combination drugs.
Go back to interactions summary
Medications known to interact with Sunosi
O
- Octocaine 100 (epinephrine / lidocaine)
- Ocu-Phrin (phenylephrine ophthalmic)
- Ocu-Zoline (naphazoline ophthalmic)
- OcuClear (oxymetazoline ophthalmic)
- Ocuhist (naphazoline / pheniramine ophthalmic)
- olodaterol
- olodaterol / tiotropium
- Omidria (ketorolac / phenylephrine ophthalmic)
- Omnihist II LA (chlorpheniramine / methscopolamine / phenylephrine)
- Omnihist L.A. (chlorpheniramine / methscopolamine / phenylephrine)
- Ongentys (opicapone)
- Onset Forte (acetaminophen / chlorpheniramine / phenylephrine)
- Opcon-A (naphazoline / pheniramine ophthalmic)
- opicapone
- Opti-Clear (tetrahydrozoline ophthalmic)
- Optigene 3 (tetrahydrozoline ophthalmic)
- Orabloc (articaine / epinephrine)
- Oratuss 12 (carbetapentane / guaifenesin / phenylephrine)
- Orlenta (chlorpheniramine / pseudoephedrine)
- Ornex (acetaminophen / pseudoephedrine)
- Ornex Maximum Strength (acetaminophen / pseudoephedrine)
- Orvaten (midodrine)
- Osmolex ER (amantadine)
- Otrivin (xylometazoline nasal)
- Oxyfrin (oxymetazoline nasal)
- Oxymeta-12 (oxymetazoline nasal)
- oxymetazoline nasal
- oxymetazoline ophthalmic
- oxymetazoline topical
- ozanimod
More about Sunosi (solriamfetol)
- Sunosi consumer information
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (75)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- FDA approval history
- Drug class: miscellaneous central nervous system agents
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.